{
    "name": "triamcinolone topical",
    "comment": "Rx",
    "other_names": [
        "Kenalog Orabase",
        "Kenalog topical",
        "Pediaderm TA",
        "Triacet",
        "Trianex"
    ],
    "classes": [
        "Corticosteroids",
        "Topical"
    ],
    "source": "https://reference.medscape.com/drug/kenalog-orabase-triamcinolone-topical-343533",
    "pregnancy": {
        "common": [
            "Pregnancy category: C",
            "Lactation: Not known whether topical corticosteroids are distributed into milk; however, systemic corticosteroids are distributed into milk; use with caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Not known whether topical corticosteroids are distributed into milk; however, systemic corticosteroids are distributed into milk; use with caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Underlying fungal, bacterial, or viral infection",
                "Hypersensitivity",
                "Ophthalmic use"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Chronic topical corticosteroid therapy may interfere with growth and development in children",
                "Use medium to very high potency for <2 weeks to reduce local and systemic side effects",
                "Use low potency for chronic therapy",
                "Avoid medium to very high potency on face, folds, and groin because can increase steroid absorption",
                "Use lower potency for children (ie, increase BSA/kg, therefore increase systemic absorption)",
                "Prolonged use may result in bacterial or fungal superinferction; discontinue if dermatological infection persists despite antimicrobial therapy",
                "Discontinue if local sensitization including irritation or redness occurs",
                "Avoid use of high potency steroids in the face",
                "May cause hypercorticism or suppression of hypothalamic-pituitary-adrenal (HPA) axis, especially in younger children or patients receiving high doses for prolonged periods; HPA axis suppression may lead to adrenal crisis",
                "Absorption may be increased by use of occlusive dressings, application to denuded skin or to large surface areas; percutaneous absorption may cause manifestations of Cushingâ€™s syndrome, hyperglycemia, or glycosuria"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Skin atrophy",
            "percent": "2"
        },
        {
            "name": "Striae",
            "percent": null
        },
        {
            "name": "Acneform lesions",
            "percent": null
        },
        {
            "name": "Pigmentation changes",
            "percent": null
        },
        {
            "name": "HPA suppression",
            "percent": null
        },
        {
            "name": "with higher potency used",
            "percent": null
        },
        {
            "name": "weeks",
            "percent": null
        }
    ]
}